187 related articles for article (PubMed ID: 25847782)
1. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of farnesyl pyrophosphate synthase prevents norepinephrine-induced fibrotic responses in vascular smooth muscle cells from spontaneously hypertensive rats.
Du CQ; Yang L; Yang J; Han J; Hu XS; Wu T; Hu SJ
Hypertens Res; 2014 Jan; 37(1):26-34. PubMed ID: 23985701
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis in vitro.
Li Z; Bi X; Wang M; Zhang J; Song J; Shen X; Han J; Fu G; Ye Y
Clin Exp Immunol; 2014 Jun; 176(3):429-37. PubMed ID: 24527834
[TBL] [Abstract][Full Text] [Related]
7. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells.
Madiraju P; Hossain E; Anand-Srivastava MB
Mol Cell Biochem; 2018 Nov; 448(1-2):77-89. PubMed ID: 29417337
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin III on c-Jun N terminal kinase in Wistar and hypertensive rat vascular smooth muscle cells.
Alanazi AZ; Clark MA
Peptides; 2020 Jan; 123():170204. PubMed ID: 31738968
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
17. [Effects of angiotensin II on extracellular signal-regulated protein kinases signaling pathway in cultured vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats].
Zhu JH; Liu Z; Huang ZY; Li S
Sheng Li Xue Bao; 2005 Oct; 57(5):587-92. PubMed ID: 16220196
[TBL] [Abstract][Full Text] [Related]
18. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
19. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
Won SM; Park YH; Kim HJ; Park KM; Lee WJ
Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.
Hitomi H; Kaifu K; Fujita Y; Sofue T; Nakano D; Moriwaki K; Hara T; Kiyomoto H; Kohno M; Kobori H; Nishiyama A
Am J Hypertens; 2011 Oct; 24(10):1149-55. PubMed ID: 21716329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
